# Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients

> **NCT01019551** · PHASE2 · COMPLETED · sponsor: **Objectif Recherche Vaccins SIDA** · enrollment: 29 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** ART Intensification
- **BIOLOGICAL:** Immunomodulation

## Key facts

- **NCT ID:** NCT01019551
- **Lead sponsor:** Objectif Recherche Vaccins SIDA
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-07
- **Final completion:** 2013-02
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2013-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01019551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01019551, "Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01019551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*